Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: February 27, 2008
Last updated: August 31, 2016
Last verified: August 2016